These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7952454

  • 21. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA, Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF.
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [Abstract] [Full Text] [Related]

  • 22. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 23. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
    Zhang J, Tao LJ, Ning JP, Xu H, Ai YH, Zhao SP.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
    [Abstract] [Full Text] [Related]

  • 24. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 25. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G, Himmerich S, Gedrich K, Wetter TC, Pollmächer T.
    Arch Intern Med; 2006 Sep 18; 166(16):1739-43. PubMed ID: 16983052
    [Abstract] [Full Text] [Related]

  • 26. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May 18; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 27. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 18; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 28. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
    Gérain J, Liénard D, Pampallona S, Baumgartner M, Rüegg C, Buurman WA, Eggermont A, Lejeune F.
    Cytokine; 1997 Dec 18; 9(12):1034-42. PubMed ID: 9417816
    [Abstract] [Full Text] [Related]

  • 29. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
    Adamik B, Zimecki M, Właszczyk A, Kübler A.
    Arch Immunol Ther Exp (Warsz); 1997 Dec 18; 45(2-3):169-75. PubMed ID: 9597083
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 31. Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resection.
    Schroder J, Gallati H, Kremer B.
    Hepatogastroenterology; 1998 Aug 15; 45(23):1807-12. PubMed ID: 9840152
    [Abstract] [Full Text] [Related]

  • 32. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
    Haseeb MA, Shirazian DJ, Preis J.
    Cytokine; 2001 Sep 07; 15(5):266-9. PubMed ID: 11594791
    [Abstract] [Full Text] [Related]

  • 33. Association between early detection of soluble TNF-receptors and mortality in burn patients.
    Ribeiro CA, Andrade C, Polanczyk CA, Clausell N.
    Intensive Care Med; 2002 Apr 07; 28(4):472-8. PubMed ID: 11967603
    [Abstract] [Full Text] [Related]

  • 34. Natural serum TNF antagonists in end-stage renal failure and following renal transplantation.
    Lambert C, Berthoux P, Vindimian M, Hacini J, Berthoux F.
    Nephrol Dial Transplant; 1994 Apr 07; 9(12):1791-6. PubMed ID: 7708266
    [Abstract] [Full Text] [Related]

  • 35. [Cytokine levels in patients with multiple injuries].
    Kantorová I, Svoboda P, Ochmann J.
    Cas Lek Cesk; 1995 Jan 18; 134(2):49-52. PubMed ID: 7712525
    [Abstract] [Full Text] [Related]

  • 36. [Changes in concentrations of tumor necrosis factor TNF and its soluble receptors type 1 (sTNF-r1) and type 2 (sTNF-R2) in serum of patients with ST-segment elevation myocardial infarction].
    Mielczarek-Palacz A, Sikora J, Kondera-Anasz Z, Smycz M.
    Wiad Lek; 2011 Jan 18; 64(2):71-4. PubMed ID: 22026268
    [Abstract] [Full Text] [Related]

  • 37. Variation in serum levels of the soluble TNF receptors among healthy individuals.
    Aderka D, Engelmann H, Shemer-Avni Y, Hornik V, Galil A, Sarov B, Wallach D.
    Lymphokine Cytokine Res; 1992 Jun 18; 11(3):157-9. PubMed ID: 1327192
    [Abstract] [Full Text] [Related]

  • 38. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.
    Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT.
    Surg Gynecol Obstet; 1990 Jan 18; 170(1):32-8. PubMed ID: 2294627
    [Abstract] [Full Text] [Related]

  • 39. [Increased plasma level of Type I (p55) and Type II (p75) TNF-receptors following trauma].
    Keel M, Bonaccio M, Steckholzer U, Ungethüm U, Gallati H, Trentz O, Ertel W.
    Swiss Surg; 1995 Jan 18; (5):241-4. PubMed ID: 7584592
    [Abstract] [Full Text] [Related]

  • 40. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
    Spielmann S, Kerner T, Ahlers O, Keh D, Gerlach M, Gerlach H.
    Acta Anaesthesiol Scand; 2001 Mar 18; 45(3):364-70. PubMed ID: 11207475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.